Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy-Reference-Cited by-同舟云学术

Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy

Published:2006-09 Issue:9 Volume:34 Page:1218-1228
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Marin Virna,Dander Erica,Biagi Ettore,Introna Martino,Fazio Grazia,Biondi Andrea,D'Amico Giovanna

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference65 articles.

1. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity;Schmidt-Wolf;J Exp Med,1991

2. Studies of ex-vivo activated and expanded CD8+ NKT cells in humans and mice;Verneris;J Clin Immunol,2002

3. Expansion of cytotoxic CD3+CD56+ cells from peripheral blood progenitor cells of patients undergoing autologous haematopoietic cell transplantation;Alvarnas;Biol Blood Marrow Transplant,2001

4. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity against leukemia and lymphoma cells by reverse antibody-dependent cellular cytotoxicity;Lu;J Immunol,1994

5. Expansion of Philadelphia chromosome-negative CD3+CD56+ cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice;Hoyle;Blood,1998

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytokine-induced killer cells: new insights for therapy of hematologic malignancies;Stem Cell Research & Therapy;2024-08-13

2. CAR Cells beyond Classical CAR T Cells: Functional Properties and Prospects of Application;Biochemistry (Moscow);2024-05

3. CAR products from novel sources: a new avenue for the breakthrough in cancer immunotherapy;Frontiers in Immunology;2024-04-11

4. The paths and challenges of “off-the-shelf” CAR-T cell therapy: An overview of clinical trials;Biomedicine & Pharmacotherapy;2023-12

5. Advances in CAR‐Engineered Immune Cell Generation: Engineering Approaches and Sourcing Strategies;Advanced Science;2023-10-31